Results 181 to 190 of about 2,249 (191)
Some of the next articles are maybe not open access.
Lebrikizumab for Moderate-to-Severe Atopic Dermatitis. Reply.
The New England journal of medicine, 2023Jonathan I, Silverberg +2 more
openaire +1 more source
The effects of lebrikizumab in patients with mild asthma following whole lung allergen challenge
Clinical and Experimental Allergy, 2014exaly
Faculty Opinions recommendation of Lebrikizumab treatment in adults with asthma.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature, 2011Frank Nestle, Federica Villanova
openaire +1 more source
Lebrikizumab in Uncontrolled Asthma: Reanalysis in a Well-Defined Type 2 Population
Journal of Allergy and Clinical Immunology: in PracticeNicola A Hanania, Peter A Lio
exaly
Lebrikizumab approval for the treatment of moderate to severe atopic dermatitis in Italy
Italian Journal of Dermatology and VenereologyArgenziano, Giuseppe +3 more
openaire +2 more sources
Faculty Opinions recommendation of Lebrikizumab treatment in adults with asthma.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature, 2012openaire +1 more source
Successful Treatment of Bullous Pemphigoid with Lebrikizumab: A Case Report
JDDG: Journal der Deutschen Dermatologischen GesellschaftLisa Grentner +3 more
openaire +1 more source